Q
uniQure NV D
D
QURE
27.030
USD
0.57
(2.15%)
Post Trading·27.000USD-0.030(-0.11%)
حجم التداول
26,786
الربح لكل سهم
-3
العائد الربحي
-
P/E
-8
حجم السوق
1,704,714,120
المقالات
العنوان: uniQure NV
القطاع: Healthcare
الصناعة: Biotechnology
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.